Silibinin induces protective superoxide generation in human breast cancer MCF-7 cells. 2010

Hong-Jun Wang, and Yuan-Yuan Jiang, and Xiao-Feng Wei, and Huai Huang, and Shin-Ichi Tashiro, and Satoshi Onodera, and Takashi Ikejima
China-Japan Research Institute of Medical and Pharmaceutical Sciences, Shenyang Pharmaceutical University, Shenyang 110016, PR China.

The pharmacological activity of polyphenolic silibinin from milk thistle (Silybum marianum) is primarily due to its antioxidant property. However, this study found that silibinin promoted sustained superoxide (O(2)(.-)) production that was specifically scavenged by exogenous superoxide dismutase (SOD) in MCF-7 cells, while the activity of endogenous SOD was not changed by silibinin. Previous work proved that silibinin induced MCF-7 cell apoptosis through mitochondrial pathway and this study further proved that O(2)(.-) generation induced by silibinin was also related to mitochondria. It was found that respiratory chain complexes I, II and III were all involved in silibinin-induced O(2)(.-) generation. Moreover, it was found that silibinin-induced O(2)(.-) had protective effect, as exogenous SOD markedly enhanced silibinin-induced apoptosis.

UI MeSH Term Description Entries
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D011505 Protein-Tyrosine Kinases Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors. Tyrosine Protein Kinase,Tyrosine-Specific Protein Kinase,Protein-Tyrosine Kinase,Tyrosine Kinase,Tyrosine Protein Kinases,Tyrosine-Specific Protein Kinases,Tyrosylprotein Kinase,Kinase, Protein-Tyrosine,Kinase, Tyrosine,Kinase, Tyrosine Protein,Kinase, Tyrosine-Specific Protein,Kinase, Tyrosylprotein,Kinases, Protein-Tyrosine,Kinases, Tyrosine Protein,Kinases, Tyrosine-Specific Protein,Protein Kinase, Tyrosine-Specific,Protein Kinases, Tyrosine,Protein Kinases, Tyrosine-Specific,Protein Tyrosine Kinase,Protein Tyrosine Kinases,Tyrosine Specific Protein Kinase,Tyrosine Specific Protein Kinases
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D005260 Female Females
D006706 Homeostasis The processes whereby the internal environment of an organism tends to remain balanced and stable. Autoregulation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077385 Silybin The major active component of silymarin flavonoids extracted from seeds of the MILK THISTLE, Silybum marianum; it is used in the treatment of HEPATITIS; LIVER CIRRHOSIS; and CHEMICAL AND DRUG INDUCED LIVER INJURY, and has antineoplastic activity; silybins A and B are diastereomers. 2,3-Dehydrosilybin,Alepa-forte,Ardeyhepan,Cefasilymarin,Durasilymarin,Hepa-Merz Sil,Hepa-loges,HepaBesch,Hepar-Pasc,Heparsyx,Heplant,Lagosa,Legalon Forte,Silibin,Silibinin,Silibinin A,Silibinin B,Silybin A,Silybin B,Silybinin,2,3 Dehydrosilybin,Alepa forte,Hepa Merz Sil,Hepa loges,Hepar Pasc
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous

Related Publications

Hong-Jun Wang, and Yuan-Yuan Jiang, and Xiao-Feng Wei, and Huai Huang, and Shin-Ichi Tashiro, and Satoshi Onodera, and Takashi Ikejima
March 2011, Journal of breast cancer,
Hong-Jun Wang, and Yuan-Yuan Jiang, and Xiao-Feng Wei, and Huai Huang, and Shin-Ichi Tashiro, and Satoshi Onodera, and Takashi Ikejima
May 2019, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
Hong-Jun Wang, and Yuan-Yuan Jiang, and Xiao-Feng Wei, and Huai Huang, and Shin-Ichi Tashiro, and Satoshi Onodera, and Takashi Ikejima
April 2010, Journal of medicinal food,
Hong-Jun Wang, and Yuan-Yuan Jiang, and Xiao-Feng Wei, and Huai Huang, and Shin-Ichi Tashiro, and Satoshi Onodera, and Takashi Ikejima
March 2019, Breast cancer (Tokyo, Japan),
Hong-Jun Wang, and Yuan-Yuan Jiang, and Xiao-Feng Wei, and Huai Huang, and Shin-Ichi Tashiro, and Satoshi Onodera, and Takashi Ikejima
February 2016, Archives of biochemistry and biophysics,
Hong-Jun Wang, and Yuan-Yuan Jiang, and Xiao-Feng Wei, and Huai Huang, and Shin-Ichi Tashiro, and Satoshi Onodera, and Takashi Ikejima
April 2020, Asian Pacific journal of cancer prevention : APJCP,
Hong-Jun Wang, and Yuan-Yuan Jiang, and Xiao-Feng Wei, and Huai Huang, and Shin-Ichi Tashiro, and Satoshi Onodera, and Takashi Ikejima
January 2007, Anticancer research,
Hong-Jun Wang, and Yuan-Yuan Jiang, and Xiao-Feng Wei, and Huai Huang, and Shin-Ichi Tashiro, and Satoshi Onodera, and Takashi Ikejima
October 1999, The Journal of nutrition,
Hong-Jun Wang, and Yuan-Yuan Jiang, and Xiao-Feng Wei, and Huai Huang, and Shin-Ichi Tashiro, and Satoshi Onodera, and Takashi Ikejima
May 1998, Cancer letters,
Hong-Jun Wang, and Yuan-Yuan Jiang, and Xiao-Feng Wei, and Huai Huang, and Shin-Ichi Tashiro, and Satoshi Onodera, and Takashi Ikejima
March 2016, Journal of breast cancer,
Copied contents to your clipboard!